LIQUIDIA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.28 USD | -2.54% |
|
-1.92% | +2.08% |
| 25/06 | Oppenheimer Initiates Liquidia at Perform | MT |
| 03/06 | Liquidia's Yutrepia Launch Cleared as Court Denies Injunction | MT |
Chart calendar Liquidia Corporation
340242ef0c4.yniux4hFBiH-P6Y_EDDs8kIGgu0PWUZZzmYStVyqo-4.qzH98MJwN02kDdRTaVyjugs37JpCPXBonBxw4QTe8L-OOuqJ-TNsbaZokg~cb125d861b498b73ea3a2a6c29f2cb07
Upcoming events on Liquidia Corporation
Past events on Liquidia Corporation
| 21/06/2024 02:00 am | Annual General Meeting |
| 05/06/2024 06:30 pm | Jefferies Global Healthcare Conference |
| 22/05/2024 11:30 pm | American Thoracic Society Conference - Naomi Habib |
| 15/05/2024 | BofA Securities Health Care Conference |
| 15/05/2024 03:13 am | Q1 2024 Earnings Release |
| 14/05/2024 06:00 pm | Q1 2024 Earnings Call |
| 09/04/2024 11:00 pm | Needham Healthcare Conference |
| 13/03/2024 06:00 pm | Q4 2023 Earnings Call |
| 13/03/2024 03:30 pm | Q4 2023 Earnings Release |
| 02/02/2024 09:50 pm | Pulmonary Vascular Research Institute Congress |
| 11/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 07/11/2023 07:00 pm | Q3 2023 Earnings Call |
| 07/11/2023 05:00 pm | Q3 2023 Earnings Release |
| 10/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 10/08/2023 03:30 pm | Q2 2023 Earnings Release |
| 28/06/2023 06:00 pm | Liquidia Corporation and Pharmosa Biopharm L606 Licensing Agreement Call |
| 16/06/2023 02:00 am | Annual General Meeting |
| 09/06/2023 07:00 pm | Jefferies Healthcare Conference |
| 22/05/2023 09:00 pm | Thoracic Society International Conference - Exploratory Efficacy Analysis of INSPIRE Open Label Exte |
| 09/05/2023 10:15 pm | Bank of America Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,07 8,07 0% | 0,74 0,00 - | 12,9 12,7 1.28% | 15,9 14,1 12.7% | 17,5 17,7 -1.16% | 55,2 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -35,1 -42,0 16.39% | -71,2 -57,2 -24.59% | -79,6 |
|
EBIT Million USD | Released Forecast Spread | -46,8 -46,4 -0.91% | -59,1 -57,5 -2.84% | -33,8 -29,2 -15.92% | -38,8 -42,3 8.26% | -73,4 -62,2 -18.03% | -92,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -47,6 -46,6 -2.21% | -59,8 -58,1 -2.79% | -34,6 -29,0 -19.24% | -41,0 -44,5 7.84% | -78,5 -66,9 -17.26% | -96,5 |
|
Net income Million USD | Released Forecast Spread | -47,6 -46,6 -2.21% | -59,8 -58,1 -2.79% | -34,6 -29,0 -19.24% | -41,0 -44,0 6.82% | -78,5 -66,9 -17.33% | -102 |
|
EPS USD | Released Forecast Spread | -2,59 -2,34 -10.68% | -1,76 -1,74 -1.29% | -0,70 -0,61 -15.7% | -0,67 -0,73 8.4% | -1,21 -1,02 -18.63% | -1,35 |
| Announcement Date | 11/03/20 | 23/03/21 | 17/03/22 | 16/03/23 | 13/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,49 3,34 4.5% | 3,92 3,53 10.94% | 3,17 3,33 -5.08% | 5,36 3,55 50.84% | 4,49 3,93 14.42% | 4,79 4,32 10.82% | 3,68 4,33 -15.13% | 4,53 4,73 -4.24% | 2,97 4,39 -32.28% | 8,95 | 16,1 | 26,8 | 38,2 | 48,5 |
|
EBITDA Million USD | Released Forecast Spread | -3,42 -10,7 68.19% | -29,0 | -15,0 | -7,34 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -14,5 -10,6 -36.16% | -8,97 -14,3 37.37% | -12,0 -10,3 -16.54% | -6,50 -9,81 33.78% | -9,23 -11,3 18.18% | -22,8 -10,6 -115.14% | -14,9 -13,7 -8.76% | -26,4 -15,1 -75.58% | -28,8 -22,4 -28.76% | -24,7 | -23,1 | -17,2 | -4,84 | 2,79 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,9 -10,7 -48.62% | -9,45 -14,6 35.51% | -9,09 -11,1 18.38% | -6,53 -10,7 39.06% | -11,7 -11,2 -5.18% | -23,5 -10,6 -121.43% | -15,8 -11,8 -34.22% | -27,5 -15,9 -72.29% | -40,9 -21,7 -88.81% | -24,7 | -23,6 | -17,1 | -7,14 | 0,49 |
|
Net income Million USD | Released Forecast Spread | -15,9 -10,7 -48.62% | -9,45 -14,6 35.51% | -9,09 -11,1 18.38% | -6,53 -10,1 35.21% | -11,7 -11,5 -2.15% | -23,5 -10,7 -119.53% | -15,8 -14,0 -13.09% | -27,5 -15,8 -73.91% | -40,9 -22,7 -79.92% | -25,6 | -24,8 | -18,5 | -7,14 | 0,49 |
|
EPS USD | Released Forecast Spread | -0,30 -0,21 -45.16% | -0,15 -0,25 40.59% | -0,14 -0,17 15.15% | -0,09 -0,16 42.2% | -0,18 -0,17 -3.85% | -0,36 -0,17 -116% | -0,24 -0,21 -12% | -0,42 -0,24 -78.19% | -0,54 -0,30 -78.02% | -0,34 | -0,32 | -0,24 | -0,28 | -0,23 |
| Announcement Date | 12/05/22 | 11/08/22 | 08/11/22 | 16/03/23 | 04/05/23 | 10/08/23 | 07/11/23 | 13/03/24 | 13/05/24 | - | - | - | - | - |
More events
Past sector events for Liquidia Corporation
| 21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
| 14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/06/2024 04:03 pm | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 02:47 pm | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 30/05/2024 05:38 pm | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 11:54 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 05:30 pm | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 02:56 pm | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LQDA Stock
- Calendar Liquidia Corporation
